Methapyrilene Toxicity: Anchorage of Pathologic Observations to Gene Expression Alterations

Methapyrilene (MP) exposure of animals can result in an array of adverse pathological responses including hepatotoxicity. This study investigates gene expression and histopathological alterations in response to MP treatment in order to 1) utilize computational approaches to classify samples derived from livers of MP treated rats based on severity of toxicity incurred in the corresponding tissue, 2) to phenotypically anchor gene expression patterns, and 3) to gain insight into mechanism(s) of methapyrilene hepatotoxicity. Large-scale differential gene expression levels associated with the exposure of male Sprague—Dawley rats to the rodent hepatic carcinogen MP for 1, 3, or 7 days after daily dosage with 10 or 100 mg/kg/day were monitored. Hierarchical clustering and principal component analysis were successful in classifying samples in agreement with microscopic observations and revealed low-dose effects that were not observed histopathologically. Data from cDNA microarray analysis corroborated observed histopathological alterations such as hepatocellular necrosis, bile duct hyperplasia, microvesicular vacuolization, and portal inflammation observed in the livers of MP exposed rats and provided insight into the role of specific genes in the studied toxicological processes.

[1]  Kate Johnson,et al.  MAPS: a microarray project system for gene expression experiment information and data validation , 2001, Bioinform..

[2]  J. Shaddock,et al.  A study of the potential genotoxicity of methapyrilene and related antihistamines using the hepatocyte/DNA repair assay. , 1984, Mutation research.

[3]  J. Shaddock,et al.  The potent hepatocarcinogen methapyrilene does not form DNA adducts in livers of Fischer 344 rats. , 1988, Mutation research.

[4]  D. Clive,et al.  The potent hepatocarcinogen methapyrilene induces mutations in L5178Y mouse lymphoma cells in the apparent absence of DNA adduct formation. , 1991, Mutation research.

[5]  S. Husain,et al.  Role of lipids, lipoproteins and vitamins in women with breast cancer. , 2001, Clinical biochemistry.

[6]  Elena Pita Calandre,et al.  Methapyrilene kinetics and dynamics , 1981, Clinical pharmacology and therapeutics.

[7]  B. K. Park,et al.  Methapyrilene hepatotoxicity is associated with increased hepatic glutathione, the formation of glucuronide conjugates, and enterohepatic recirculation. , 2000, Chemico-biological interactions.

[8]  G. S. Ratra,et al.  Effects of induction and inhibition of cytochromes P450 on the hepatotoxicity of methapyrilene. , 1998, Toxicological sciences : an official journal of the Society of Toxicology.

[9]  I. Jolliffe Principal Component Analysis , 2002 .

[10]  B. Caillou,et al.  Identification of genes overexpressed in tumors through preferential expression screening in trophoblasts. , 1994, Cancer research.

[11]  M. Bittner,et al.  Expression profiling using cDNA microarrays , 1999, Nature Genetics.

[12]  T. Kitamura,et al.  Identification and characterization of a novel gene (neurorep 1) expressed in nerve cells and up-regulated after axotomy , 1997, Neuroscience.

[13]  L. Terracciano,et al.  Proliferation, but not growth, blocked by conditional deletion of 40S ribosomal protein S6. , 2000, Science.

[14]  Y. Sasaki,et al.  Identification of genes highly expressed in G2‐arrested Chinese hamster ovary cells by differential display analysis , 2000, Journal of clinical laboratory analysis.

[15]  W. Lijinsky,et al.  A comparison of in vivo and in vitro metabolites of the H1-antagonist N,N-dimethyl-N'-2-pyridyl-N'-(2-thienylmethyl)-1,2-ethanediamine (methapyrilene) in the rat. , 1987, Xenobiotica; the fate of foreign compounds in biological systems.

[16]  G. Rush,et al.  Effects of methapyrilene measured in mitochondria isolated from naive and methapyrilene-treated rat and mouse hepatocytes. , 1992, Toxicology and applied pharmacology.

[17]  W. Lijinsky,et al.  Liver tumors induced in rats by oral administration of the antihistaminic methapyrilene hydrochloride. , 1980, Science.

[18]  M. Pike,et al.  Increased cell division as a cause of human cancer. , 1990, Cancer research.

[19]  M. Cunningham,et al.  The hepatocarcinogen methapyrilene but not the analog pyrilamine induces sustained hepatocellular replication and protein alterations in F344 rats in a 13-week feed study. , 1995, Toxicology and applied pharmacology.

[20]  H. Yamamura,et al.  An activated S6 kinase in regenerating rat liver. , 1987, Biochemical and biophysical research communications.

[21]  B. Frei,et al.  Ca2+ release from mitochondria induced by prooxidants. , 1988, Free radical biology & medicine.

[22]  S. Wrighton,et al.  Modulation of rat hepatic cytochromes P450 by chronic methapyrilene treatment. , 1991, Biochemical pharmacology.

[23]  E. Levy,et al.  Altered lipid profile, lipoprotein composition, and oxidant and antioxidant status in pediatric Crohn disease. , 2000, The American journal of clinical nutrition.

[24]  P. Alberti,et al.  Activation of a Ribosomal S6 Protein Kinase in Rapidly Emerging Diethylnitrosamine-Induced Gamma - Glut Amyltranspeptidase-Positive Hyperplastic Liver Lesions of the Rat , 1989, Tumori.

[25]  M. Cunningham,et al.  Role of increased DNA replication in the carcinogenic risk of nonmutagenic chemical carcinogens. , 1996, Mutation research.

[26]  T. Mohandas,et al.  Regional mapping of human chromosome 19: organization of genes for plasma lipid transport (APOC1, -C2, and -E and LDLR) and the genes C3, PEPD, and GPI. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[27]  E. Hölttä,et al.  Ornithine decarboxylase activity and the accumulation of putrescine at early stages of liver regeneration , 1972, FEBS letters.

[28]  L. M. Brennan,et al.  The effects of methapyrilene hydrochloride on hepatocarcinogenicity and pentobarbital-induced sleeping time in rats and mice. , 1982, Toxicology and applied pharmacology.

[29]  T. Russo,et al.  Differentially expressed mRNAs as a consequence of oxidative stress in intact cells , 1995, FEBS letters.

[30]  J. Bucher,et al.  14-Week toxicity and cell proliferation of methyleugenol administered by gavage to F344 rats and B6C3F1 mice. , 2001, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[31]  R. Fisher,et al.  The S29 ribosomal protein increases tumor suppressor activity of K rev-1 gene on v-K ras-transformed NIH3T3 cells. , 1996, Biochimica et biophysica acta.

[32]  D. Casciano,et al.  Methapyrilene is inactive in the hepatocyte-mediated Chinese hamster ovary/hypoxanthine-guanine phosphoribosyl transferase mutational assay. , 1984, Cancer letters.

[33]  W. Lijinsky,et al.  Failure of methapyrilene to induce tumors in hamsters or guinea pigs. , 1983, Journal of toxicology and environmental health.

[34]  Y. Chen,et al.  Ratio-based decisions and the quantitative analysis of cDNA microarray images. , 1997, Journal of biomedical optics.

[35]  J. Mirsalis Genotoxicity, toxicity, and carcinogenicity of the antihistamine methapyrilene. , 1987, Mutation research.

[36]  W. Lijinsky Chronic toxicity tests of pyrilamine maleate and methapyrilene hydrochloride in F344 rats. , 1984, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[37]  M. Lampe,et al.  Species differences in the metabolism and macromolecular binding of methapyrilene: a comparison of rat, mouse and hamster. , 1990, Xenobiotica; the fate of foreign compounds in biological systems.

[38]  Y. Marcel,et al.  Apolipoprotein A-I: structure-function relationships. , 2000, Journal of lipid research.

[39]  W. Lijinsky,et al.  Inability of methapyrilene to induce sister chromatid exchanges in vitro and in vivo. , 1982, Cancer research.

[40]  R G Ulrich,et al.  Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity. , 2001, Toxicology letters.

[41]  M. Wright,et al.  Methapyrilene hepatotoxicity is associated with oxidative stress, mitochondrial disfunction and is prevented by the Ca2+ channel blocker verapamil. , 1998, Toxicology.

[42]  Kammerer Rc,et al.  Species differences in the in vitro metabolism of methapyrilene. , 1987 .

[43]  S. Orrenius,et al.  Further characterization of the events involved in mitochondrial Ca2+ release and pore formation by prooxidants. , 1994, Biochemical pharmacology.

[44]  G. Eisenbrand,et al.  Carcinogenicity of methapyrilene hydrochloride, mepyramine hydrochloride, thenyldiamine hydrochloride, and pyribenzamine hydrochloride in Sprague-Dawley rats , 2004, Journal of Cancer Research and Clinical Oncology.

[45]  N. Anderson,et al.  Dose-responses in rat hepatic protein modification and expression following exposure to the rat hepatocarcinogen methapyrilene. , 1994, Carcinogenesis.

[46]  J. Johnson,et al.  Two-year toxicity and carcinogenicity study of methyleugenol in F344/N rats and B6C3F(1) mice. , 2000, Journal of agricultural and food chemistry.

[47]  P. Bushel,et al.  Detection of diluted gene expression alterations using cDNA microarrays. , 2002, BioTechniques.

[48]  W. Lijinsky,et al.  Lack of binding of methapyrilene and similar antihistamines to rat liver DNA examined by 32P postlabeling. , 1988, Cancer research.

[49]  R G Ulrich,et al.  Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles. , 2001, Toxicology and applied pharmacology.

[50]  I. Wool,et al.  Ribosomal protein genes are overexpressed in colorectal cancer: isolation of a cDNA clone encoding the human S3 ribosomal protein , 1991, Molecular and cellular biology.

[51]  J. Spalding,et al.  Examination of genotoxicity, toxicity and morphologic alterations in hepatocytes following in vivo or in vitro exposure to methapyrilene. , 1988, Carcinogenesis.

[52]  H. Matthews,et al.  Cell proliferation as a determining factor for the carcinogenicity of chemicals: studies with mutagenic carcinogens and mutagenic noncarcinogens. , 1995, Toxicology letters.

[53]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[54]  Lee Bennett,et al.  Gene expression analysis reveals chemical-specific profiles. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[55]  H. Reznik-Schüller,et al.  Ultrastructural changes in the liver of animals treated with methapyrilene and some analogs. , 1982, Ecotoxicology and environmental safety.

[56]  G. Bellomo,et al.  4-Hydroxynonenal as a biological signal: molecular basis and pathophysiological implications. , 1999, Antioxidants & redox signaling.

[57]  S. Wang,et al.  Identification and characterization of differentially expressed genes in the early response phase during liver regeneration. , 2000, Biochemical and biophysical research communications.

[58]  Xiu-qin Wang,et al.  Cloning and characterization of full-length human ribosomal protein L15 cDNA which was overexpressed in esophageal cancer. , 2001, Gene.

[59]  J. Jänne,et al.  Biosynthesis of putrescine: characterization of ornithine decarboxylase from regenerating rat liver. , 1968, Acta chemica Scandinavica.

[60]  M. Garriott,et al.  The evaluation of methapyrilene for bacterial mutation with metabolic activation by Aroclor-induced, methapyrilene-induced and noninduced rat-liver S9. , 1993, Mutation research.